Lannett Company Inc. recalls Niacin Extended-release Tablets
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Failed Dissolution Specifications: during 12M LT stability testing OOS low for Stage 3 dissolution at the 24-hour timepoint.
- Products
-
- Niacin Extended-release Tablets
- Company
- Lannett Company Inc.
- Where it was sold
-
Nationwide within the United States
Nationwide
- Units affected
- 3984 bottles
- About this recall
- Niacin Extended-release Tablets, USP, 1,000 mg, 90-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC 62175-322-46.